Nicox S Ais A French Ophthalmology Company Based In Sophia Antipolisfounded In 1996The Company Is Dedicated To Developing Innovative Therapeutics Aimed At Maintaining Vision And Enhancing Ocular Healthnicox Is Publicly Traded On Euronext Paris Under The Ticker Symbol Cox And Is Included In Key Indexes Such As The Cac Healthcare And Cac Pharma & Bio The Company Focuses On Biotechnology Solutions For Ophthalmic Conditionswith A Pipeline That Includes Several Notable Productsits Lead Candidatencx 470Is Designed To Lower Intraocular Pressure In Glaucoma Patients And Is Currently In Phase 3 Clinical Developmentother Products Include Ncx 4251 For Treating Blepharitisvyzultawhich Is Fda Approved For Glaucomaand Zerviatean Ophthalmic Solution For Allergic Conjunctivitisnicox Collaborates With Prominent Companies Like Bausch & Lombeyevance Pharmaceuticalsand Ocumension Therapeutics To Enhance Its Presence In The Global Ophthalmology Market
No conferences found for this company.
| Company Name | Nicox Ophthalmics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
